Cardio IQ® CYP2C19 Genotype
Test Code
Clinical Significance
Cardio IQ® CYP2C19 Genotype - This pharmacogenetic test may be used to help guide clopidogrel prescribing, especially in patients with acute coronary syndrome (ACS) who have undergone percutaneous coronary intervention (PCI) [1]. This test detects common variants in the CYP2C19 gene, the most validated genetic determinant of clopidogrel response.
Clopidogrel is a prodrug that needs to be metabolized to its active form by cytochrome P450 2C19 (CYP2C19). Patients who carry a no-function allele of CYP2C19 have reduced clopidogrel activation, reduced platelet inhibition, and higher risk of major adverse cardiovascular ...
Test Resources
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Methodology
Reference Range(s)
Alternative Name(s)
Preferred Specimen(s)
4 mL whole blood collected in an EDTA (lavender-top) tube
Minimum Volume
2 mL
Collection Instructions
Multiple (up to 8) cardiovascular-related genetic tests can be performed on a single specimen. A second EDTA (lavender- top) tube is required if non-genetic tests are simultaneously ordered that require an EDTA (lavender-top) tube. For whole blood samples, follow normal phlebotomy procedures.
Transport Container
EDTA (lavender-top)
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
- Room temperature: 8 days
- Refrigerated: 8 days
- Frozen: 30 days
Setup Schedule
Refrigerated: 8 days
Frozen: 30 days